Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rohto is a globally recognized brand of over-the-counter (OTC) ophthalmic solutions developed by Rohto Pharmaceutical. The brand encompasses a wide range of formulations tailored for various ocular conditions, including eye redness, dryness, itchiness, and fatigue. A hallmark of many Rohto products is the signature cooling sensation provided by ingredients like menthol, which target the TRPM8 receptor. The product line includes flagship brands such as V Rohto, Rohto Dry Aid, and Algard. Active ingredients typically include vasoconstrictors like naphazoline or tetrahydrozoline to reduce redness, antihistamines like pheniramine for allergy relief, and various lubricants and vitamins to support ocular health. Rohto also produces the V5 line, which focuses on dietary supplements for vision support.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rohto.